Company / FCF Margin
Niagen Bioscience, Inc. FCF Margin History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-45.8%
FY2019
5-year range
-
FY2016-FY2019
Trend
+11.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -51.7% to -45.8% over the past 2 years.
Based on SEC 10-K filings.
-45.8% in FY2019 with a 3-year CAGR of -25.3%.
Improved from -51.7% to -45.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -25.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, fcf margin increased 11.6% year-over-year.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -45.8% | +11.6% |
| FY2018 | -51.7% | +0.0% |
| FY2017 | -51.7% | -152.4% |
| FY2016 | -20.5% | -39.1% |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026